VenuGopalBathiniMD
Oncology • Framingham, MAAssistant Professor, Medicine, University Massachusetts Medical School
Dr. Bathini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
571 Union Ave
Ste 202
Framingham, MA 01702Phone+1 508-665-6261Fax+1 508-665-4175
Education & Training
UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 2003 - 2006
Beth Israel Deaconess Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 2002 - 2003- UMass Chan Medical SchoolResidency, Internal Medicine, 1999 - 2002
Chicago Medical School/Rosalind Franklin University of Medicine ScienceInternship, Transitional Year, 1998 - 1999
Kakatiya Medical College NTRClass of 1995
Certifications & Licensure
MA State Medical License 2002 - 2025
FL State Medical License 2006 - 2010
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- A Trial of Chemo & Radiation Therapy for Pancreatic Cancer Start of enrollment: 2006 Jun 01
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
Publications & Presentations
PubMed
- 17 citationsA phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metast...B H O'Neil, A J Scott, W W Ma, S J Cohen, D L Aisner
Annals of Oncology. 2015-09-01 - 134 citationsNab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.Philip A. Philip, Jill Lacy, Fabienne Portales, Alberto Sobrero, Roberto Pazo-Cid
The Lancet. Gastroenterology & Hepatology. 2020-03-01 - 8 citationsHeterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.Xiaoqin Zhu, Mohammed Salhab, Keith Tomaszewicz, Xiuling Meng, Carol Mathew
Human Pathology. 2019-03-01
Journal Articles
- Original Contribution Heterogeneous Mutational Profile and Prognosis Conferred by TP53 Mutations in Appendiceal Mucinous Neoplasms☆Ediz F Cosar, Mohammed Salhab, Otto Walter, Laura A Lambert, Carol Mathew, Xiaofei Wang, Venu Bathini, ScienceDirect
Press Mentions
University of Massachusetts Hematology Oncology FellowshipApril 30th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
